Search

Home > New FDA Approvals > 028 - FDA OKs Prevymix to block infection after marrow transplant; Second Sight receives expedited access pathway for Orion; FDA to accelerate approval for direct-to-consumer genetic tests


	Podcast:		New FDA Approvals
	Episode:		028 - FDA OKs Prevymix to block infection after marrow transplant; Second Sight receives expedited access pathway for Orion; FDA to accelerate approval for direct-to-consumer genetic tests
	Category:		Science & Medicine
	Duration:		00:04:14
	Publish Date:		2017-11-09 06:00:00
	Description:		November 9, 2017 0:26 FDA OKs drug to block infection after marrow transplant http://www.mrknewsroom.com/news-release/prescription-medicine-news/merck-receives-fda-approval-prevymis-letermovir-prevention-c 0:51 Second Sight Receives Expedited Access Pathway for Orion http://investors.secondsight.com/releasedetail.cfm?ReleaseID=1010479 1:59 FDA to accelerate approval for direct-to-consumer genetic tests https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm583885.htm If we can help with any medical writing, please reach out to us at info@nascentmc.com Our US-based company, Nascent Medical, LLC, has a team of over 100 PhD-/MD-level writers who can write about any medical, scientific or technical topic. We charge a flat rate and provide an upfront estimate. Our turn around times can be as short as 1 to 2 days depending on the length of the project, and we don't charge extra for our speediness. Have you updated your blog or posted any press releases lately? That's a small project that some clients like to test us out with to start. We do the following types of writing, including but not limited to: -Video and virtual reality script writing -eLearning scripts -Medical education -Webinar slide creation -Manuscripts -Slidesets -Manuscripts -Press releases -Blog posts -Annual reports -Proposals -White papers -Web content -Posters -Sales training materials
	Total Play:		0